Evading immune surveillance via tyrosine phosphorylation of nuclear PCNA
Open Access
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 36 (8) , 109537
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare (MOHW107-TDU-B-212-112015)
- China Medical University Hospital (DMR-CELL-17025)
- Ministry of Science and Technology, Taiwan (MOST-106-2320-B-039-049, MOST-108-2320-B-039-002)
- National Health Research Institutes (NHRI-EX110-11012BI)
- China Medical University, Taiwan (CMU107-TU-01)
- Breast Cancer Research Foundation (BCRF-17-069)
This publication has 68 references indexed in Scilit:
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsGenome Biology, 2013
- Targeting the EGFR/PCNA Signaling Suppresses Tumor Growth of Triple-Negative Breast Cancer Cells with Cell-Penetrating PCNA PeptidesPLOS ONE, 2013
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and CufflinksNature Protocols, 2012
- Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- γH2AX and cancerNature Reviews Cancer, 2008
- Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patientsBreast Cancer Research and Treatment, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005